A study to assess the safety, tolerability and pharmacokinetics of AZD7594 inhaled formulation in healthy Japanese men

Trial Identifier:	D3741C00005
Sponsor:	AstraZeneca
NCTID::	NCT02645253
Start Date:	January 2016
Primary Completion Date:	April 2016
Study Completion Date:	April 2016
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States of America, CA	Glendale, CA, United States of America, 91206

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.